The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST Academic Article uri icon

Overview

MeSH Major

  • Cerebral Hemorrhage
  • Fibrinolytic Agents
  • Health Status Indicators
  • Thrombolytic Therapy
  • Tissue Plasminogen Activator

abstract

  • The THRIVE score predicts the risk of symptomatic intracranial hemorrhage after intravenous tissue plasminogen activator administration. This external validation of the relationship between THRIVE and symptomatic intracranial hemorrhage in a prospective study further strengthens the role of the THRIVE score in the prediction of poststroke outcomes.

publication date

  • January 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/ijs.12335

PubMed ID

  • 25042855

Additional Document Info

start page

  • 705

end page

  • 10

volume

  • 9

number

  • 6